Position in GH
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$5,004,606
-$977,427 QoQ
Shares Held
54,180
-7.5% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026F/m Investments LLC holds $23,225,997 across 6 Diagnostics & Research names. GH ranks #2 (21.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
26,493 | $14,886,151 | |
| 2 | GH |
Guardant Health, Inc.
This page
|
54,180 | $5,004,606 | |
| 3 | BLLN |
BillionToOne, Inc.
|
16,908 | $1,334,717 | |
| 4 | TWST |
Twist Bioscience Corp
|
17,850 | $848,232 | |
| 5 | RDNT |
RadNet, Inc.
|
14,899 | $832,705 | |
| 6 | NEO |
Neogenomics Inc
|
43,071 | $319,586 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,004,606 | 54,180 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,982,033 | 58,567 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $2,949,305 | 47,204 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,034,711 | 39,099 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,645,552 | 38,628 | Shares | Sole | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||